張 彥俊

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Healthcare-Associated Pneumonia 82%
3. Bacterial Pneumonia 82%
4. Ventilator-Associated Pneumonia 80%
5. Video-Assisted Thoracic Surgery 79%
6. Thoracoscopy 78%
7. Extracorporeal Membrane Oxygenation 74%
8. Pneumothorax 68%
9. Photochemotherapy 68%
10. Adenocarcinoma of Lung 67%
11. Airway Obstruction 66%
12. Postoperative Pain 63%
13. ErbB Receptors 60%
14. Protein-Tyrosine Kinases 57%
15. Epidemiology 49%
16. Radiotherapy 43%
17. Thorax 43%
18. Length of Stay 29%
19. Lung 28%
20. Anti-Bacterial Agents 27%
21. Acinetobacter baumannii 25%
22. Enterobacteriaceae 23%
23. Therapeutics 23%
24. Neoplasms 22%
25. Pseudomonas aeruginosa 19%
26. Operative Time 19%
27. oxacillinase 18%
28. ceftazidime drug combination avibactam 17%
29. Chryseobacterium 17%
30. Carbapenem-Resistant Enterobacteriaceae 15%
31. Stenotrophomonas maltophilia 14%
32. Tigecycline 14%
33. Segmental Mastectomy 14%
34. Thoracic Surgery 14%
35. Non-Small Cell Lung Carcinoma 14%
36. carbapenemase 14%
37. Antimicrobial Stewardship 13%
38. Colistin 13%
39. Comorbidity 12%
40. Mortality 11%
41. Klebsiella pneumoniae 11%
42. Methicillin-Resistant Staphylococcus aureus 10%
43. Gram-Negative Bacteria 10%
44. Adenocarcinoma 9%
45. Conversion to Open Surgery 9%
46. Recurrence 9%
47. Lymph Nodes 8%
48. Chest Tubes 8%
49. Sepsis 8%
50. PubMed 8%